Teleflex Incorporated (NYSE:TFX) Stake Reduced by Yousif Capital Management LLC

Yousif Capital Management LLC decreased its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 1.0% in the 4th quarter, HoldingsChannel.com reports. The firm owned 7,218 shares of the medical technology company’s stock after selling 75 shares during the period. Yousif Capital Management LLC’s holdings in Teleflex were worth $1,285,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the business. Cromwell Holdings LLC boosted its holdings in Teleflex by 59.0% in the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock worth $33,000 after purchasing an additional 49 shares in the last quarter. Apollon Wealth Management LLC lifted its position in shares of Teleflex by 3.7% in the third quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock worth $377,000 after buying an additional 55 shares during the last quarter. SRS Capital Advisors Inc. boosted its stake in shares of Teleflex by 0.3% during the 3rd quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock worth $4,844,000 after acquiring an additional 60 shares in the last quarter. Janney Montgomery Scott LLC increased its holdings in shares of Teleflex by 0.4% during the 3rd quarter. Janney Montgomery Scott LLC now owns 15,332 shares of the medical technology company’s stock valued at $3,792,000 after acquiring an additional 65 shares during the last quarter. Finally, Tokio Marine Asset Management Co. Ltd. increased its holdings in shares of Teleflex by 4.5% during the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,517 shares of the medical technology company’s stock valued at $375,000 after acquiring an additional 66 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Truist Financial lowered their target price on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research note on Wednesday, December 18th. Mizuho cut their target price on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st. Finally, Royal Bank of Canada decreased their price target on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a report on Friday, November 1st. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, Teleflex presently has a consensus rating of “Moderate Buy” and an average price target of $252.50.

Teleflex Price Performance

NYSE:TFX opened at $167.60 on Friday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. Teleflex Incorporated has a one year low of $166.90 and a one year high of $256.85. The company has a fifty day moving average price of $178.87 and a 200 day moving average price of $210.08. The stock has a market cap of $7.78 billion, a P/E ratio of 33.32, a PEG ratio of 1.72 and a beta of 1.16.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.